When was Epigenica founded?

Epigenica was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is Epigenica located?

Epigenica is headquartered in Stockholm, Sweden.

Who is the current CEO of Epigenica?

Mohamad Takwa of Epigenica. They have also founded 1 company.

How many employees does Epigenica have?

As of Aug 31, 2026, the latest employee count at Epigenica is 21.

Is Epigenica a funded company?

Epigenica is a funded company, having raised a total of $2.2M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 01, 2022.

When was the latest funding round of Epigenica?

Epigenica's latest funding was a $***** Seed round on Jun 30, 2025, with participation from 4 investors.

Where does Epigenica rank among its competitors?

Epigenica ranks 6th amongst 29 active competitors, of which 11 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was EpiCypher, which secured $3.04M in Dec, 2025.

Who are the top competitors of Epigenica?

Epigenica's top competitors include Biomodal, FOXO Technologies and Moonwalk. Among them, EpiCypher secured the most recent funding round in December, 2025.

Epigenica - 2026 Company Profile, Team, Funding & Competitors

Epigenica is a seed company based in Stockholm (Sweden), founded in 2020 by Mohamad Takwa and Simon Alsatian. It operates as a Provider of solutions for the analysis of genomic data. Epigenica has raised $2.2M in funding from Voima Ventures. The company has 29 active competitors, including 11 funded and 5 that have exited. Its top competitors include companies like Biomodal, FOXO Technologies and Moonwalk.

Company Details

Provider of solutions for the analysis of genomic data. The platform is offering tools, EpiQure, for testing epigenetic drug efficacy and toxicity screening in real-life pilots, EpiFinder, for large-scale biomarker discovery for disease diagnosis and prognosis, and EpIVD, which helps in lowering the cost of epigenetic diagnostics.

Website: www.epigenica.se/
Email ID: *****@epigenica.se

Key Metrics

Founded Year

2020

Location

Stockholm, Sweden

Stage

Seed

Total Funding

$2.2M in 2 rounds

Latest Funding Round

Seed, Jun 30, 2025, $*****

Investors

Voima Ventures & 5 more

Ranked

6^th among 29 active competitors

Employee Count

21 as on Aug 31, 2026

Similar Companies

Biomodal & 31 more

View Epigenica's full profile

Epigenica has raised a total funding of $2.2M over 2 rounds. Its first funding round was on Jul 01, 2022. Its latest funding round was a Seed round on Jun 30, 2025 for $*****. 4 investors participated in its latest round. Epigenica has 6 institutional investors.

Here is the list of recent funding rounds of Epigenica:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 30, 2025	7460958	Seed	7099763	6905884	7941408	3201105
Jul 01, 2022	4355969	Grant (prize money)	3859288	7291590	4781735	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Epigenica's funding rounds and investors

The founders of Epigenica are Mohamad Takwa and Simon Alsatian. Mohamad Takwa is the CEO of Epigenica.

Here are the details of Epigenica's key team members:

Mohamad Takwa: Co-Founder & CEO of Epigenica.
Contact Info: 1 email address
Simon Alsatian: Co-Founder of Epigenica.

View details of Epigenica's Founder profiles and Board Members

Epigenica's employee count trend

Epigenica has 21 employees as of Aug 26. Here is Epigenica's employee count trend over the years:

Uncover Epigenica's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Epigenica include Biomodal, FOXO Technologies and Moonwalk. Here is the list of Top 10 competitors of Epigenica, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biomodal 2012, Cambridge (United Kingdom), Series D	Developer of a duet multiomics platform that generates genetic and epigenetic data	$164M	Temasek, Google Ventures & 23 others	63/100
2nd	FOXO Technologies 2020, Minneapolis (United States), Public	Provider of epigenetic biomarkers discovery and development platform	$40M	Bespoke Growth Partners, Inc., Centrecourt Asset Management ... Read more	60/100
3rd	Moonwalk 2022, San Francisco (United States), Series A	Digital platform pioneering precision epigenetic medicines	$57M	Google Ventures, Alpha Wave Global & 3 others	60/100
4th	EpiCypher 2012, Chapel Hill (United States), Series A	Provider of epigentic kits, reagents and assays for research purpose	$3.43M	NCBiotech, HHS	57/100
5th	Active Motif 1999, Carlsbad (United States), Funding Raised	Provider of research kits, assays and biocomputing systems	-	Broadoak Capital Partners, HHS & 1 others	52/100
6th	Epigenica 2020, Stockholm (Sweden), Seed	Provider of solutions for the analysis of genomic data	$2.2M	Almi Invest, Leksell Social Ventures & 4 others	45/100
7th	Chroma Medicine 2020, Cambridge (United States), Series B	Developer of an epigenetic editing platform for genomic medicines	$260M	Atlas Venture, Google Ventures & 16 others	45/100
8th	Chronomics 2017, Norwich (United Kingdom), Seed	Provider of an online digital platform for epigenetics data	$1.43M	SOSV, Anthemis Group & 3 others	42/100
9th	Reaction Biology 2001, United States, Late Stage	In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling	-	Cobepa, CYwP Funds & 6 others	40/100
10th	Yijie Like Shanghai (China), Seed	Developer of epigenetic regulation technology to treat a variety of diseases	$14.8M	Morningside, Xicheng Jinrui & 3 others	37/100